To demonstrate that LR-PCA is a useful tool in studying dynamic association of disease-associated proteins with rafts and therefore may benefit pharmaceutical studies, we applied our assay to examine APP, whose connection to rafts and cholesterol may contribute in pathogenesis of Alzheimer’s disease (AD) [62,63]. The gene discussed is APP; the disease is early-onset autosomal dominant Alzheimer disease.